fda_approval · nda · info

NOVARTIS — NDA approval: KISQALI FEMARA CO-PACK (COPACKAGED) (unspecified)

Event date: 2026-07-01 00:00:00Z
Observed: 2026-07-09 22:53:26Z
Source ID: NDA209935-33
Payload hash: 2d4b40c46e7d7952ddc471b3…

Summary

NOVARTIS received a priority supplemental NDA approval for KISQALI FEMARA CO-PACK (COPACKAGED) (unspecified) on 2026-07-01. Dosage form: TABLET. Application #: NDA209935.

Entities

NOVARTIS

View source record ↗

Informational only. Not legal, financial, or medical advice.